Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 59 Records) |
| Query Trace: Neutropenia and ABCB1[original query] |
|---|
| Impact of Genetic Polymorphisms on 6-Thioguanine Nucleotide Levels and Toxicity in Pediatric Patients with IBD Treated with Azathioprine. Inflammatory bowel diseases 2015 Aug . Lee Mi-Na, Kang Ben, Choi So Yoon, Kim Mi Jin, Woo Sook Young, Kim Jong-Won, Choe Yon Ho, Lee Soo-Yo |
| ABCC5 and ABCG1 polymorphisms predict irinotecan-induced severe toxicity in metastatic colorectal cancer patients. Pharmacogenetics and genomics 2015 Sep . Chen Sylvia, Villeneuve Lyne, Jonker Derek, Couture Félix, Laverdière Isabelle, Cecchin Erica, Innocenti Federico, Toffoli Giuseppe, Lévesque Eric, Guillemette Chant |
| Genetic risk factors for clozapine-induced neutropenia and agranulocytosis in a Dutch psychiatric population. The pharmacogenomics journal 2016 May . van der Weide K, Loovers H, Pondman K, Bogers J, van der Straaten T, Langemeijer E, Cohen D, Commandeur J, van der Weide |
| Effects of UGT1A1*6, UGT1A1*28, and ABCB1-3435C>T polymorphisms on irinotecan induced toxicity in Chinese cancer patients. International journal of clinical pharmacology and therapeutics 2016 Feb . Yan Liang, Wang Xiao-Fei, Wei Lu-Man, Nie Ya-Li, Liu Jing-Yang, Zhang Li-Ro |
| Association of ABCB1 and SLC22A16 Gene Polymorphisms with Incidence of Doxorubicin-Induced Febrile Neutropenia: A Survey of Iranian Breast Cancer Patients. PloS one 2016 12 11 (12): e0168519. Faraji Abolfazl, Dehghan Manshadi Hamid Reza, Mobaraki Maryam, Zare Mahkameh, Houshmand Masso |
| Drug-related genetic polymorphisms affecting severe chemotherapy-induced neutropenia in breast cancer patients: A hospital-based observational study. Medicine 2016 Nov 95 (44): e5151. Tsuji Daiki, Ikeda Midori, Yamamoto Keisuke, Nakamori Harumi, Kim Yong-Il, Kawasaki Yohei, Otake Aki, Yokoi Mari, Inoue Kazuyuki, Hirai Keita, Nakamichi Hidenori, Tokou Umi, Shiokawa Mitsuru, Itoh Kunihi |
| ABC transporter polymorphisms are associated with irinotecan pharmacokinetics and neutropenia. The pharmacogenomics journal 2018 01 18 (1): 35-42. Li M, Seiser E L, Baldwin R M, Ramirez J, Ratain M J, Innocenti F, Kroetz D |
| Impact of ABC single nucleotide polymorphisms upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia. Leukemia & lymphoma 2016 Oct 1-10. Megías-Vericat Juan Eduardo, Montesinos Pau, Herrero María José, Moscardó Federico, Bosó Virginia, Rojas Luis, Martínez-Cuadrón David, Hervás David, Boluda Blanca, García-Robles Ana, Rodríguez-Veiga Rebeca, Martín-Cerezuela María, Cervera José, Sendra Luis, Sanz Jaime, Miguel Antonio, Lorenzo Ignacio, Poveda José Luis, Sanz Miguel Ángel, Aliño Salvador |
| Pharmacogenetic determinants of outcomes on triplet hepatic artery infusion and intravenous cetuximab for liver metastases from colorectal cancer (European trial OPTILIV, NCT00852228). British journal of cancer 2017 Aug . Lévi Francis, Karaboué Abdoulaye, Saffroy Raphaël, Desterke Christophe, Boige Valerie, Smith Denis, Hebbar Mohamed, Innominato Pasquale, Taieb Julien, Carvalho Carlos, Guimbaud Rosine, Focan Christian, Bouchahda Mohamed, Adam René, Ducreux Michel, Milano Gérard, Lemoine Antoinet |
| Irinotecan toxicity during treatment of metastatic colorectal cancer: focus on pharmacogenomics and personalized medicine. Tumori 2018 12 106 (2): 87-94. Paulík Adam, Nekvindová Jana, Filip Stanisl |
| Prediction of neutrophil reduction using plasma paclitaxel concentration after administration in patients with uterine, ovarian, or cervical cancers in an outpatient clinic. Cancer chemotherapy and pharmacology 2018 1 81 (2): 399-411. Ishikawa Motoaki, Kawai Michiyasu, Maeda Toshio, Kagawa Yoshiyu |
| CYP2J27 Genotype Predicts Risk of Chemotherapy-Induced Hematologic Toxicity and Reduced Relative Dose Intensity in Ethiopian Breast Cancer Patients. Frontiers in pharmacology 2019 5 10 481. Ahmed Jemal Hussien, Makonnen Eyasu, Yimer Getnet, Seifu Daniel, Bekele Abebe, Assefa Mathewos, Aseffa Abraham, Howe Rawleigh, Fotoohi Alan, Hassan Moustapha, Aklillu Ele |
| Impact of gene polymorphisms on the systemic toxicity to paclitaxel/carboplatin chemotherapy for treatment of gynecologic cancers. Archives of gynecology and obstetrics 2019 May . de Castro Clarissa Lourenço, da Costa Junior Luiz Carlos, Lourenço Letícia Vieira, Seba Karine Souza, da Silva Taiana Sousa Lopes, Vianna-Jorge Rosa |
| Genetic variation in the ATP binding cassette transporter ABCC10 is associated with neutropenia for docetaxel in Japanese lung cancer patients cohort. BMC cancer 2019 Mar 19 (1): 246. Sone Kazuki, Oguri Tetsuya, Uemura Takehiro, Takeuchi Akira, Fukuda Satoshi, Takakuwa Osamu, Maeno Ken, Fukumitsu Kensuke, Kanemitsu Yoshihiro, Ohkubo Hirotsugu, Takemura Masaya, Ito Yutaka, Niimi Ak |
| ABCB1 and ABCC2 genetic polymorphism as risk factors for neutropenia in esophageal cancer patients treated with docetaxel, cisplatin, and 5-fluorouracil chemotherapy. Cancer chemotherapy and pharmacology 2020 Aug . Nomura Hisanaga, Tsuji Daiki, Demachi Ken, Mochizuki Nobuo, Matsuzawa Haruki, Yano Tomonori, Daiko Hiroyuki, Fujii Satoshi, Kojima Takashi, Itoh Kunihiko, Kawasaki Toshikat |
| Effect of drug metabolizing enzymes and transporters in Thai colorectal cancer patients treated with irinotecan-based chemotherapy. Scientific reports 2020 Aug 10 (1): 13486. Atasilp Chalirmporn, Chansriwong Phichai, Sirachainan Ekaphop, Reungwetwattana Thanyanan, Sirilerttrakul Suwannee, Chamnanphon Monpat, Puangpetch Apichaya, Sukasem Chonlaph |
| ABCB1 Genetic Variants as Predictors of Irinotecan-Induced Severe Gastrointestinal Toxicity in Metastatic Colorectal Cancer Patients. Frontiers in pharmacology 2020 7 11 973. Riera Pau, Artigas-Baleri Alícia, Salazar Juliana, Sebio Ana, Virgili Anna C, Arranz María Jesús, Páez Dav |
| The influence of single-nucleotide polymorphisms on overall survival and toxicity in cabazitaxel-treated patients with metastatic castration-resistant prostate cancer. Cancer chemotherapy and pharmacology 2020 Jan . Belderbos Bodine P S, de With Mirjam, Singh Rajbir K, Agema Bram C, El Bouazzaoui Samira, Oomen-de Hoop Esther, de Wit Ronald, van Schaik Ron H N, Mathijssen Ron H J, Bins Sand |
| Evaluation of the Association of Polymorphisms With Palbociclib-Induced Neutropenia: Pharmacogenetic Analysis of PALOMA-2/-3. The oncologist 2021 5 26 (7): e1143-e1155. Iwata Hiroji, Umeyama Yoshiko, Liu Yuan, Zhang Zhe, Schnell Patrick, Mori Yuko, Fletcher Olivia, Marshall Jean-Claude, Johnson Jillian G, Wood Linda S, Toi Masakazu, Finn Richard S, Turner Nicholas C, Bartlett Cynthia Huang, Cristofanilli Massi |
| Meta-Analysis of ABCG2 and ABCB1 Polymorphisms With Sunitinib-Induced Toxicity and Efficacy in Renal Cell Carcinoma. Frontiers in pharmacology 2021 3 12 641075. Sun Fengjun, Chen Zhuo, Yao Pu, Weng Bangbi, Liu Zhirui, Cheng L |
| Pharmacokinetic interactions between clozapine and valproic acid in patients with treatment-resistant schizophrenia: Does UGT polymorphism affect these drug interactions? Chemico-biological interactions 2022 Jul 364 110042. Sangüesa Estela, Cirujeda Christine, Concha Julia, Padilla Pedro Pablo, García Cristina Belén, Ribate María Pil |
| Effects of ABCB1 and ABCG2 polymorphisms on the pharmacokinetics of abemaciclib. European journal of clinical pharmacology 2022 May . Maeda Akimitsu, Ando Hitoshi, Irie Kei, Hashimoto Naoya, Morishige Jun-Ichi, Fukushima Shoji, Okada Akira, Ebi Hiromichi, Matsuzaki Masahide, Iwata Hiroji, Sawaki Masata |
| Pharmacogenetic Profiling in High-Risk Soft Tissue Sarcomas Treated with Neoadjuvant Chemotherapy. Journal of personalized medicine 2022 4 12 (4): . Virgili Manrique Anna C, Salazar Juliana, Arranz María Jesús, Bagué Silvia, Orellana Ruth, López-Pousa Antonio, Cerdà Paula, Gracia Isidre, Majercakova Katarina, Peiró Ana, Trullols Laura, Fernández Manuel, Valverde Sandra, Quintana María Jesús, Bell Olga, Artigas-Baleri Alícia, Sebio A |
| The Relation of Haplotype ATP-binding Cassette B1 and Glutathione S-transferase P1 A313G Genes with Hematological Toxicity in Indonesian Breast Cancer Patients Receiving Chemotherapy. Oman medical journal 2022 4 37 (2): e357. Syarifah Siti, Widyawati Tri, Hasni Dita, Sari Mutiara Indah, Rusdiana Rusdiana, Hamdi Tasr |
| Association of ADME gene polymorphisms on toxicity to CDK4/6 inhibitors in patients with HR+ HER2- metastatic breast cancer. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2023 9 167 115479. Elena Peruzzi, Lorenzo Gerratana, Marcella Montico, Bianca Posocco, Serena Corsetti, Michele Bartoletti, Sara Gagno, Marco Orleni, Elena De Mattia, Massimo Baraldo, Erika Cecchin, Fabio Puglisi, Giuseppe Toffoli, Rossana Ronca |
| A polymorphism in ABCA2 is associated with neutropenia induced by capecitabine in Japanese patients with colorectal cancer. Cancer chemotherapy and pharmacology 2023 8 . Yukitaka Shibata, Natsumi Matsumoto, Remi Murase, Yutaro Kubota, Hiroo Ishida, Ken Shimada, Ken-Ichi Fuji |
| Genetic variants of genes involved in thiopurine metabolism pathway are associated with 6-mercaptopurine toxicity in pediatric acute lymphoblastic leukemia patients from Ethiopia. Frontiers in pharmacology 2023 5 14 1159307. Awol Mekonnen Ali, Haileyesus Adam, Daniel Hailu, Ephrem Engidawork, Rawleigh Howe, Teferra Abula, Marieke J H Coen |
| Personalized Medicine in Infant Population with Cancer: Pharmacogenetic Pilot Study of Polymorphisms Related to Toxicity and Response to Chemotherapy. Cancers 2023 3 15 (5): . Urtasun Andrea, Olivera Gladys G, Sendra Luis, Aliño Salvador F, Berlanga Pablo, Gargallo Pablo, Hervás David, Balaguer Julia, Juan-Ribelles Antonio, Andrés María Del Mar, Cañete Adela, Herrero María Jo |
| Potential association of SULT2A1 and ABCG2 variant alleles with increased risk for palbociclib toxicity. Pharmacogenomics 2024 8 1-9. Chong Wang, Mary Hwang, Brandon Paulson, Doreen Mhandire, Sadat Ozair, Tracey L O'Connor, Shipra Gandhi, Kristopher M Attwood, Daniel L Hertz, Andrew Kl Go |
| Impact of ABCB1 single-nucleotide variants on early, extremely severe neutropenia induced by paclitaxel/nanoparticle albumin-bound paclitaxel in patients with gastric cancer. British journal of clinical pharmacology 2024 12 . Akimitsu Maeda, Keitaro Matsuo, Hitoshi Ando, Jun-Ichi Morishige, Kei Muro, Kosaku Uchida, Masahiro Taji |
- Page last reviewed:Feb 1, 2024
- Content source: